Onesource Specialty Pharma Stock

Onesource Specialty Pharma Gross Profit

The Gross Profit of Onesource Specialty Pharma (ONESOURCE.NS) as of Aug 14, 2026 is 9.74 B INR. In the previous year, Gross Profit was 812.80 M INR — a change of 1,097.95% (higher).

Gross Profit

9.74 BINR

YoY

1,097.95%

Last updated:

Gross Profit of Onesource Specialty Pharma is 2026 9.74 B INR. Gross Profit of Onesource Specialty Pharma was 2025 812.80 M INR. It decreases by 1,097.95% higher compared to the previous year.

The Onesource Specialty Pharma Gross Profit history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

GROSS MARGIN (%)
Date
GROSS MARGIN (%)
Jan 1, 2023
-4.60 base
Jan 1, 2024
47.28 base
Jan 1, 2025
67.39 base
Jan 1, 2026 (e)
72.59 base
Jan 1, 2027 (e)
43.66 base
Jan 1, 2028 (e)
28.71 base
YEARGROSS MARGIN (%)
2028 est 28.71
2027 est 43.66
2026 est 72.59
2025 67.39
2024 47.28
2023 -4.60
Access this data via the Eulerpool API
Get Free API Key

Onesource Specialty Pharma Revenue

Onesource Specialty Pharma Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
387.14 M INR
-2.16 B INR
-8.00 B INR
Jan 1, 2024
1.72 B INR
-1.58 B INR
-3.91 B INR
Jan 1, 2025
14.45 B INR
1.94 B INR
-179.71 M INR
Jan 1, 2026 (e)
13.41 B INR
522.76 M INR
-323.80 M INR
Jan 1, 2027 (e)
22.30 B INR
869.21 M INR
4.14 B INR
Jan 1, 2028 (e)
33.91 B INR
1.32 B INR
8.55 B INR

Onesource Specialty Pharma Margins

Onesource Specialty Pharma stock margins

The Onesource Specialty Pharma margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Onesource Specialty Pharma. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Onesource Specialty Pharma.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
-4.60 %
-559.21 %
-2,066.00 %
Jan 1, 2024
47.28 %
-91.99 %
-227.53 %
Jan 1, 2025
67.39 %
13.46 %
-1.24 %
Jan 1, 2026 (e)
67.39 %
3.90 %
-2.41 %
Jan 1, 2027 (e)
67.39 %
3.90 %
18.55 %
Jan 1, 2028 (e)
67.39 %
3.90 %
25.20 %

Onesource Specialty Pharma Stock analysis

What does Onesource Specialty Pharma do? Onesource Specialty Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Onesource Specialty Pharma stock

Gross Profit of Onesource Specialty Pharma is 9.74 B INR in 2026.

Gross Profit of Onesource Specialty Pharma changed from 812.80 M INR to 9.74 B INR, representing a 1,097.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Profit Onesource Specialty Pharma since 2006 – with annual values, charts, and detailed analysis.

Gross Profit is the revenue remaining after deducting the cost of goods sold. It shows how efficiently a company uses its resources to produce goods or services.

Gross Profit's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Gross Profit's Onesource Specialty Pharma historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Onesource Specialty Pharma

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Onesource Specialty Pharma